Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

This study has been completed.
Follow-on African Consortium for Tenofovir Studies (FACTS)
United States Agency for International Development (USAID)
Information provided by (Responsible Party):
CONRAD Identifier:
First received: June 28, 2011
Last updated: April 16, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2014
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)